NovaBridge Biosciences (NBP) Operating Income (2019 - 2025)
NovaBridge Biosciences (NBP) reported Operating Income of -$72.9 million for Q4 2025, down 445.21% year-over-year from $21.1 million in Q4 2024, and down 710.99% quarter-over-quarter from -$9.0 million in Q3 2025.
NovaBridge Biosciences (NBP) Operating Income (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 5 years of Operating Income data on file, last reported at -$72.9 million in Q4 2025.
- Operating Income for Q4 2025 came in at -$72.9 million, down 445.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$94.3 million (down 83.31% YoY), and the FY2025 annual result was -$94.3 million, down 83.31% from the prior year.
- Operating Income eased to -$72.9 million in Q4 2025 per NBP's latest filing, from -$9.0 million in the prior quarter.
- Over five years, Operating Income peaked at -$5.3 million in Q1 2025 and troughed at -$72.9 million in Q4 2025.
- A 3-year average of -$18.9 million and a median of -$12.0 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2024 and 2025: Operating Income jumped 66.12% in 2024, then slumped 445.21% in 2025.
- A 3-year view of Operating Income shows it stood at -$39.5 million in 2023, then jumped by 66.12% to -$13.4 million in 2024, then tumbled by 445.21% to -$72.9 million in 2025.
- Business Quant data shows NBP's Operating Income at -$72.9 million in Q4 2025, -$9.0 million in Q3 2025, and -$7.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -72.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.90 Mn |
| Sep 30, 2025 | -8.99 Mn |
| Jun 30, 2025 | -7.11 Mn |
| Mar 31, 2025 | -5.27 Mn |
| Dec 31, 2024 | -13.37 Mn |
| Sep 30, 2024 | -12.41 Mn |
| Jun 30, 2024 | -17.14 Mn |
| Mar 31, 2024 | -8.50 Mn |
| Dec 31, 2023 | -39.46 Mn |
| Sep 30, 2023 | -10.63 Mn |
| Jun 30, 2023 | -12.05 Mn |
| Dec 31, 2020 | 175.76 Mn |
| Sep 30, 2020 | 88.52 Bn |
| Dec 31, 2019 | -47.37 Mn |
| Sep 30, 2019 | -43.72 Mn |